Related Experiment Video
Updated: May 27, 2025

Postoperative Ileus Murine Model
Published on: July 12, 2024
Exploring the causal relationship between constipation and ileus: Insights from bidirectional Mendelian randomization
Zhengping Xiao1, Xi Xiao2, Guole Nie1
1Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Constipation significantly increases the risk of developing ileus, a serious surgical condition. This study reveals a shared genetic basis and potential molecular pathways, like nucleic acid metabolism, linking these two gastrointestinal disorders.
Area of Science:
- Gastroenterology and Genetics
- Investigating the complex interplay between functional gastrointestinal disorders and surgical emergencies.
Background:
- Constipation affects 15% globally, with increasing incidence due to modern lifestyles.
- Ileus, a surgical emergency, often co-occurs with constipation, but their relationship is poorly understood.
Purpose of the Study:
- To elucidate the causal relationship and underlying molecular mechanisms connecting constipation and ileus.
- To identify shared genetic factors and biochemical pathways involved in the development of both conditions.
Main Methods:
- Bidirectional 2-sample Mendelian randomization (MR) analysis using the IEU OpenGWAS database.
- Identification of co-expressed genes via eQTL datasets and pathway analysis using Gene Ontology, KEGG, and GeneMANIA.
- Construction of protein-protein interaction (PPI) networks to pinpoint key molecular players.
Main Results:
- MR analysis demonstrated a significant causal link between constipation and an elevated risk of ileus (OR=1.467, P<.001).
- Six genes were found to be co-expressed in both constipation and ileus.
- Enrichment analyses implicated nucleic acid metabolism and ribosomal biosynthesis, with UPB1 identified as a key gene.
Conclusions:
- Constipation and ileus share a causal relationship with significant underlying genetic susceptibility.
- Biochemical pathways, including nucleic acid metabolism and ribosomal biosynthesis, may mediate the link, with UPB1 as a potential therapeutic target.
- This study provides novel insights into the genetic basis of constipation and ileus, paving the way for targeted interventions.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

